Market closed
Camp4 Therapeutics Corporation/$CAMP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Camp4 Therapeutics Corporation
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.
Ticker
$CAMP
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
55
Website
CAMP Metrics
BasicAdvanced
$61M
-
-$11.04
-
-
Price and volume
Market cap
$61M
52-week high
$5.74
52-week low
$3.01
Financial strength
Current ratio
6.916
Quick ratio
6.683
Long term debt to equity
8.81
Total debt to equity
13.83
Interest coverage (TTM)
-2,041.85%
Management effectiveness
Return on assets (TTM)
-49.80%
Return on equity (TTM)
-101.99%
Valuation
Price to revenue (TTM)
21.796
Price to book
0.97
Price to tangible book (TTM)
0.97
Price to free cash flow (TTM)
-0.309
Growth
Revenue change (TTM)
86.29%
Earnings per share change (TTM)
-91.15%
CAMP News
AllArticlesVideos
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewsWire·1 week ago
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
GlobeNewsWire·3 weeks ago
CORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Camp4 Therapeutics Corporation stock?
Camp4 Therapeutics Corporation (CAMP) has a market cap of $61M as of April 06, 2025.
What is the P/E ratio for Camp4 Therapeutics Corporation stock?
The price to earnings (P/E) ratio for Camp4 Therapeutics Corporation (CAMP) stock is 0 as of April 06, 2025.
Does Camp4 Therapeutics Corporation stock pay dividends?
No, Camp4 Therapeutics Corporation (CAMP) stock does not pay dividends to its shareholders as of April 06, 2025.
When is the next Camp4 Therapeutics Corporation dividend payment date?
Camp4 Therapeutics Corporation (CAMP) stock does not pay dividends to its shareholders.
What is the beta indicator for Camp4 Therapeutics Corporation?
Camp4 Therapeutics Corporation (CAMP) does not currently have a Beta indicator.